Please use this identifier to cite or link to this item:
Journal Title: Achieving equitable access to cancer care and clinical trials in regional Australia: A networked approach to expand capacity and implement COSA teletrials model
49th Annual Meeting of the Clinical Oncology Society of Australia, COSA's 2022. Brisbane, QLD Australia.
Authors: Underhill, Craig
Long, Donna
Collins, Ian M.
Brown, Stephen
Harris, Samuel
Torres, Javier
Campbell, David
Lankovic, Kurt
Shaw, Michelle
Faisal, Wasek
Wright, Tricia
Rachakonda, Krishna
SWH Author: Collins, Ian M.
Keywords: Adult
Cancer Diagnosis
Cancer Model
Cancer Patient
Conference Abstract
Controlled Study
Health Services Research
Intervention Study
Major Clinical Study
Public Hospital
Issue Date: 2022
Date Accessioned: 2023-04-12T02:09:33Z
Date Available: 2023-04-12T02:09:33Z
Description Affiliation: Border Medical Oncology, Border Medical Oncology Research Unit, Albury, NSW, Australia Latrobe University, Wodonga, Vic, Australia Victorian Comprehensive Cancer Centre, Parkville, Vic, Australia UNSW School of Clinical Medicine, Rural Clinical Campus, Albury, NSW, Australia Southwest Healthcare, Warrnambool, Vic, Australia Grampians Health, Ballarat, Vic, Australia Bendigo Health, Bendigo, Vic, Australia Goulburn Valley Health, Shepparton, Vic, Australia Andrew Love Cancer Centre, University Hospital, Geelong, VIC, Australia Cancer Trials Australia, Parkville, Vic, Australia Latrobe Regional Hospital, Traralgon, Vic, Australia Mildura Base Public Hospital, Mildura, Vic, Australia
Format Startpage: 86
Source Volume: 18
Issue Number: Supplement 3
Date: 2022
Abstract: Aim: People with cancer living in regional Victoria are less likely to participate in a clinical trial than metropolitan patients. We established a new geographically based trials network with the goal of increasing the number of regional cancer patients recruited to clinical trials. Method(s): Initially six regional services and Cancer Trials Australia (CTA) collaborated to form Regional Trials Network Victoria (RTNV). Two more sites, Latrobe Regional Hospital and Mildura Public Hospital were added in 2021. This network represents a population of 1.9 million people and approximately 8000 new cancer diagnoses each year. Access to cancer clinical trials at regional sites was achieved by: Building capacity of regional clinical trial units Improving the efficiency of clinical trial conduct Implementing the COSA teletrial framework Investing in the capability of staff Increasing the number of clinical trials Results: In 2017, the CCV Clinical Trial Management Scheme (CTMS) recorded 1587 Victorians recruited to cancer clinical intervention trials. 428 resided in regional Victoria, but only 81 of these participated at a regional site, with others needing to travel. In 2017, 135 patients were recruited to RTN sites (regional plus Geelong) across 55 trials. By 2021, despite the impacts of the COVID19 pandemic the number of recruiting clinical trials increased by 54% and the number of regional patients recruited to CTMS studies in the network increased to 179. Driven by uptake of teletrials and registry trials total recruitment increased to 620 patients. RTNV leveraged funding to sustain core activity and was awarded $18.5 million from the Medical Research Future Fund to conduct health services research over the next 5 years. Conclusion(s): The RTNV is a successful implementation of a regionally based clinical trials network, improving access and participation of regional patients. Much of the increase was driven by the use of COSA Teletrials methodology.
Journal Title: Asia-Pacific Journal of Clinical Oncology
Type: Conference Paper
Conference Name: 49th Annual Meeting of the Clinical Oncology Society of Australia, COSA's 2022.
Conference Location: Brisbane, QLD Australia.
Appears in Collections:SWH Staff Publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Google Media

Google ScholarTM

Who's citing